Occurence of sjorgen's syndrome associated with the use of immune checkpoint inhibitors (ICI)
Latest Information Update: 10 Feb 2020
At a glance
- Drugs Durvalumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Cancer; Lung cancer; Malignant melanoma; Renal cancer
- Focus Therapeutic Use
- 10 Feb 2020 New trial record